Exelixis (EXEL) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.94
- Estimate
- $0.90
- Surprise
- +4.0%
- Revenue (period 2026-10-02)
- $658.7M
- Score at report (before → after)
- 6.4 → 6.2/10
Revenue source: xbrl.
How the report landed
Exelixis (EXEL) beat the $0.90 estimate with adjusted EPS of $0.94 — a clear 4.0% upside surprise. TrendMatrix's engine moved from Buy (Wait) (6.4/10) to Hold at 6.2/10 after the report — the engine's score fell despite the beat.
Where TrendMatrix's rating stands now
TrendMatrix currently rates EXEL Hold at 6.1/10.
4 of the last 4 quarters beat the estimate; this quarter's +4.0% surprise compares with a +10.0% four-quarter average. Next scheduled report: 2027-02-09.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=9.2 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Concentration risk — Product: cabozantinib
- Analyst target reached - limited upside remaining
- Negative momentum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $65.83
- Entry target
- $65.16
- Stop
- $61.99
The stock trades at 20.4× trailing but 16.0× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-19 — shown for context, not personalized investment advice.
EXEL at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Biotechnology
- Market cap
- $16.66B
- P/E (fwd)
- 16.0
- P/E (ttm)
- 20.4
- 52-week range
- $39.71–$73.69
- Off 52-week high
- 10.7%
- RSI (14)
- 41
- Volume vs avg
- 0.92×
- Score today
- 6.1/10